OPT — Optima Health Cashflow Statement
0.000.00%
- £267.59m
- £370.95m
- £120.64m
Annual cashflow statement for Optima Health, fiscal year end - March 31st, GBP millions except per share, conversion factor applied.
2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -0.511 | 0.714 | -0.856 | 2.58 | 2.47 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | -0.01 | 0.087 | 0.349 | 0.358 | 1.15 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -2.55 | -4.42 | 2.58 | -10.7 | 0.416 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Payable / Accrued Expenses | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -0.836 | 6.59 | 12.8 | 2.69 | 15.2 |
| Capital Expenditures | -0.796 | -3.88 | -2.85 | -3.75 | -3.13 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 8.57 | 4.72 | 0 | -1.9 | -102 |
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 7.77 | 0.843 | -2.85 | -5.65 | -105 |
| Financing Cash Flow Items | -0.017 | -0.134 | -0.135 | -0.441 | -1.02 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -0.205 | -1.61 | -1.63 | -3.33 | 96.5 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 6.73 | 5.82 | 8.37 | -6.3 | 6.81 |